CCHO is thrilled to announce the acceptance of two abstracts, developed in collaboration with esteemed healthcare leaders from the Ministries of Health of Saudi Arabia and Iraq, for presentation at ISPOR Europe 2024!
Poster 1: Implementation of a National Value-Based Insurance Drug Formulary in the Saudi Private Health Sector
Authors: Ahmed Hamdan Aljedai, Ibrahim Abdulrahman Aljuffali, Shabab AlGhamdi, Muhammed Aljumah, Myriam Bechwati, Racha Sabbagh Dit Hawasli, Nada Ahmed Alagil.
CCHO is proud to have co-authored the abstract “Implementation of a National Value-Based Insurance Drug Formulary in the Saudi Private Health Sector” with esteemed healthcare leaders of the UDF project in Saudi Arabia. The poster was presented at ISPOR Europe 2024, held in person at the Barcelona International Convention Center in Barcelona, Spain. It featured during Poster Session #1 on Monday, November 18, 2024, with a discussion period from 12:30 to 13:30 (Acceptance Code: HPR30).
Poster 2: Assessing Direct Medical Costs of Stage IV NSCLC in Iraq from a Public Payer Perspective
Authors: Batoul Ali AlGaban, Tuqa Muayad Al-Malahwish, Mariam AbdulSalam Jummah, Ayad Rateb Al-Asadi, Youmna Bassil.
CCHO is honored to have collaborated with distinguished healthcare executives from the Ministry of Health of Iraq on the study “Assessing Direct Medical Costs of Stage IV NSCLC in Iraq from a Public Payer Perspective”. This poster was also presented at ISPOR Europe 2024, during Poster Session #5 on Wednesday, November 20, 2024, with a discussion period from 9:00 to 10:00 (Acceptance Code: EE840). The team was excited to share these insights and engage in meaningful discussions with fellow experts in the field!